Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial.

Por Dipika Sur, Suman Kanungo, Binod Sah, Byomkesh Manna, Mohammad Ali, Allison M Paisley, Swapan K Niyogi, Jin Kyung Park, Banawarilal Sarkar, Mahesh K Puri, Deok Ryun Kim, Jacqueline L Deen, Jan Holmgren, Rodney Carbis, Raman Rao, Thu Van Nguyen, Seung Hyun Han, Stephen Attridge, Allan Donner, Nirmal K Ganguly, Sujit K Bhattacharya, G Balakrish Nair, John D Clemens, Anna Lena Lopez
Publicado em 2011-10-01